fremanezumab
Showing 1 - 19 of 19
Migraine Trial (Fremanezumab, Placebo)
Not yet recruiting
- Migraine
- Fremanezumab
- Placebo
- (no location specified)
Aug 12, 2022
Cadasil, Migraine Trial (Fremanezumab, Placebo)
Withdrawn
- Cadasil
- Migraine
- Fremanezumab
- Placebo
- (no location specified)
Feb 14, 2022
Interstitial Cystitis Trial (fremanezumab)
Withdrawn
- Interstitial Cystitis
- fremanezumab
- (no location specified)
Nov 5, 2021
Migraine, MDD Trial in Worldwide (Fremanezumab, Placebo)
Completed
- Migraine
- Major Depressive Disorder
- Fremanezumab
- Placebo
-
Little Rock, Arkansas
- +63 more
Dec 7, 2022
Migraine Trial in Worldwide (Fremanezumab)
Recruiting
- Migraine
- Fremanezumab
-
Phoenix, Arizona
- +65 more
Aug 23, 2022
Migraine Trial in Worldwide (Fremanezumab)
No longer available
- Migraine
- Fremanezumab
-
Brugge, Belgium
- +22 more
Nov 10, 2021
CGRP Inhibition, Autonomic Function, and Migraine
Recruiting
- Episodic Migraine
- Chronic Migraine
- Erenumab
- +2 more
-
Vienna, AustriaMedical University of Vienna
Apr 8, 2022
Post-Traumatic Headache Trial in United States (Fremanezumab, Placebo)
Completed
- Post-Traumatic Headache
- Fremanezumab
- Placebo
-
Phoenix, Arizona
- +32 more
Nov 5, 2021
Migraine Trial in Worldwide (Fremanezumab, Placebo)
Recruiting
- Migraine
- Fremanezumab
- Placebo
-
Phoenix, Arizona
- +86 more
Aug 23, 2022
Migraine Trial in Worldwide (Fremanezumab, Placebo)
Recruiting
- Migraine
- Fremanezumab
- Placebo
-
Phoenix, Arizona
- +86 more
Aug 23, 2022
Migraine Prophylaxis Trial in Worldwide (Fremanezumab, Placebo)
Completed
- Migraine Prophylaxis
- Fremanezumab
- Placebo
-
Huntsville, Alabama
- +112 more
Nov 5, 2021
Episodic Cluster Headache Trial in Worldwide (Fremanezumab, Placebo)
Terminated
- Episodic Cluster Headache
- Fremanezumab
- Placebo
-
Phoenix, Arizona
- +81 more
Nov 6, 2021
Chronic Cluster Headache Trial in Worldwide (Fremanezumab, Placebo)
Terminated
- Chronic Cluster Headache
- Fremanezumab
- Placebo
-
Phoenix, Arizona
- +82 more
Nov 5, 2021